CPhI China is the main event in the pharmaceutical industry throughout Asia. It takes place once a year in Shanghai and is open to trade visitors only. As the sister of CPhI worldwide, which was founded in 1990 as an international chemical and pharmaceutical fair, the CPhI China has itself internationally established.

It combines all the key suppliers and customers in the chemical and pharmaceutical industry. Exhibitors are required to take the possibilities at CPhI to meet potential new customers and partners and to strengthen existing relationships. However, new markets can be reached by the international presence.

By cooperating with the co-located fairs P-MEC China, ICSE China, LABWorld China, InnoPack China and BioPh China the entire value chain of the pharmaceutical and biotechnological industry is presented. All major Chinese supplier of pharmaceutical ingredients, outsourcing, equipment and bio-solutions are represented in the same location. The entire pharmaceutical industry is achieved, thus creating tremendous synergies in terms of ideas and information exchange in the industry.

The CPhI China in Shanghai took place from Wednesday, 20. June to Friday, 22. June 2018.

Additional News

  • 17 December 2025

    PF 2026: Thank You from Quinta-Analytica

    In 2025, Quinta-Analytica continued to turn complex development challenges into tangible progress. Our PF 2026 message looks back at key milestones and thanks the partners, clients, and teams who made them possible.

  • 15 December 2025

    IVBE for locally acting drugs: insights from Conscio Science Day in Munich

    Can bioequivalence for locally acting drugs be demonstrated without a single subject in a clinical trial? Yes, if your in vitro bioequivalence (IVBE) toolkit is set up in the right way.

  • 20 November 2025

    Webinar: Streamlined Evidence Strategies for Biosimilars: Analytics, PK and Immunogenicity in focus

    On behalf of Conscio Group, we are pleased to invite you to the upcoming free educational webinar from biosimilar series.